Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy

Lasers in Surgery and Medicine

Volumn 37, Issue 2, 2005, Pages 114-122

  Chen, Hsin Ming ^a,b   Yu, Chuan Hang ^b   Tu, Ping Chin ^b   Yeh, Chien Yang ^b   Tsai, Tsuimin ^c   Chiang, Chun Pin ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

5 aminolevulinic acid; Oral leukoplakia; Oral verrucous hyperplasia; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; LEUKOPLAKIA; MALE; MOUTH DISEASE; ORAL VERRUCOUS HYPERPLASIA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE;

ADMINISTRATION, TOPICAL; ADULT; AGED; AMINOLEVULINIC ACID; CARCINOMA, VERRUCOUS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERPLASIA; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PRECANCEROUS CONDITIONS; TREATMENT OUTCOME;

EID: 24644507158     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/lsm.20214     Document Type: Article

References (30)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
3. Lingen M, Sturgis EM, Kies MS. Squamous cell carcinoma of the head and neck in nonsmokers: Clinical and biologic characteristics and implications for management. Curr Opin Oncol 2001;13:176-182.
4. Cancer Registry Annual Report in Taiwan Area, 2001. Department of Health, The Executive Yuan, Taiwan, 2004.
5. Chen YK, Huang HC, Lin LM, Lin CC. Primary oral squamous cell carcinoma: An analysis of 703 cases in southern Taiwan. Oral Oncol 1999;35:173-179.
6. Neville BW, Damm DD, Allen CM, Bouquot JE. Epithelial pathology. In: Neville BW, Damm DD, Allen CM, Bouquot JE, editors. Oral Maxillofacial Pathology. 2nd edn. Philadelphia: W.B. Sauders; 2002;315-387.
7. Karrer S, Szeimies RM, Hohenleutner U, Landthaler M. Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy. Am J Clin Dermatol 2001;2:229-237.
8. Kubler A, Haase T, Rheinwald M, Barth T, Muhling J. Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. Int J Oral Maxillofac Surg 1998;27:466-469.
9. Sieron A, Namyslowski G, Misiolek M, Adamek M, Kawczyk-Krupka A. Photodynamic therapy of premalignant lesions and local recurrence of laryngeal and hypopharyngeal cancers. Eur Arch Oto-Rhino-Laryngol 2001;258:349-352.
10. Sieron A, Adamek M, Kawczyk-Krupka A, Mazur S, Ilewicz L. Photodynamic therapy (PDT) using topically applied 5-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. J Oral Pathol Med 2003;32:330-336.
11. Tsai JC, Chiang CP, Chen HM, Huang SB, Wang CW, Lee MI, Hsu YC, Chen CT, Tsai T. Photodynamic therapy of oral dysplasia with topical 5-aminolevulinic acid and light-emitting diode array. Lasers Surg Med 2004;34:18-24.
12. Chen HM, Chen CT, Yang H, Kuo MYP, Kuo YS, Lan WH, Wang YP, Tsai T, Chiang CP. Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Oral Oncol 2004;40:630-637.
13. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003;3:380-387.
14. Kennedy JC, Marcus SL, Pottier RH. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): Mechanisms and clinical results. J Clin Laser Med Surg 1996;14: 289-304.
15. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogeneous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol B Biol 1990;6:143-148.
16. Grant WE, Hopper C, MacRobert AJ, Speight PM, Bown SG. Photodynamic therapy of oral cancer: Photosensitisation with systemic aminolaevulinic acid. Lancet 1993;342:147-148.
17. Fan KF, Hopper C, Speight PM, Buonaccorsi G, MacRobert AJ, Bown SG. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer 1996;78:1374-1383.
18. Chen HM, Chen CT, Yang H, Lee MI, Kuo MYP, Kuo YS, Wang YP, Tsai TM, Chiang CP. Successful treatment of an extensive verrucous carcinoma with topical 5-aminolevulinic acid-mediated photodynamic therapy. J Oral Pathol Med 2005;34:253-256.
19. Barr H, Shepherd NA, Dix A, Roberts DJ, Tan WC, Krasner N. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996;348: 584-585.
20. Gossner L, Stolte M, Sroka R, Rick K, May A, Hahn EG, Ell C. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterol 1998;114:448-455.
21. Ackroyd R, Brown NJ, Davis MF, Stephenson TJ, Marcus SL, Stoddard CJ, Johnson AG, Reed MW. Photodynamic therapy for dysplastic Barrett's oesophagus: A prospective, double blind, randomized, placebo controlled trial. Gut 2000;47:612-617.
22. Bodner K, Bodner-Adler B, Wierrani F, Kubin A, Szolts-Szolts J, Spangler B, Grunberger W. Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: A comparison of preliminary results. Anticancer Res 2003;23:1785-1788.
23. Berger AP, Steiner H, Stenzl A, Akkad T, Bartsch G, Holtl L. Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: A single-center study. Urology 2003;61:338-341.
24. Waidelich R, Stepp H, Baumgartner R, Weninger E, Hofstetter A, Kriegmair M. Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer. J Urol 2001;165:1904-1907.
25. Gold MH, Goldman MP. 5-Aminolevulinic acid photodynamic therapy: Where we have been and where we are going. Dematol Surg 2004;30:1077-1083.
26. Gupta AK, Ryder JE. Photodynamic therapy and topical aminolevulinic acid: An overview. Am J Clin Dermatol 2003; 4:699-708.
27. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM. 5-aminolevulinic acid-based photodynamic therapy. Cancer 1997;79:2282-2308.
28. Leunig A, Rick K, Stepp H, Gutmann R, Alwin G, Baumgartner R, Feyh J. Fluorescence imaging and spectroscopy of 5-aminolevulinic acid induced protoporphyrin IX for the detection of neoplastic lesions in the oral cavity. Am J Surg 1996;172:674-677.
29. Leunig A, Betz CS, Mehlmann M, Stepp H, Arbogast S, Grevers G, Baumgartner R. Detection of squamous cell carcinoma of the oral cavity by imaging 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Laryngoscope 2000;110:78-83.
30. Leunig A, Mehlmann M, Betz C, Stepp H, Arbogast S, Grevers G, Baumgartner R. Fluorescence staining of oral cancer using a topical application of 5-aminolevulininc acid: Fluorescence microscopic studies. J Photochem Photobiol B Biol 2001;60:44-49.